← Browse by Condition
Medical Condition

postprandial distress syndrome

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06696261 Phase 3
Recruiting

A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome

Enrollment
342 pts
Location
China
Sponsor
Tasly Pharmaceutical Group Co....
View Trial →